Response in blood to mogamulizumab in Sézary syndrome. Patient had received 6 prior systemic therapies. Total CD3⁺ lymphocytes from peripheral blood are shown. Red, circulating cutaneous T-cell lymphoma cells; green, normal CD3⁺CD4⁺ cells; blue, normal CD3⁺CD4⁻ cells.